期刊论文详细信息
Purinergic Signalling
Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells
Valentina Di Liberto1  Silvana Buccella2  Patricia Giuliani3  Mariachiara Zuccarini4 
[1] McMaster University;University of Catania;University of Palermo;“G.d’Annunzio” University of Chieti-Pescara
关键词: P1/P2 purinergic receptors;    Epithelial to mesenchymal transition;    Fibrosis;    Transforming growth factor β1;    Madin Darby canine kidney cells;   
DOI  :  10.1007/s11302-017-9571-6
学科分类:分子生物学,细胞生物学和基因
来源: Springer
PDF
【 摘 要 】

Epithelial to mesenchymal transition (EMT) occurs during embryogenesis or under pathological conditions such as hypoxia, injury, chronic inflammation, or tissue fibrosis. In renal tubular epithelial cells (MDCK), TGF-β1 induces EMT by reducing or increasing epithelial or mesenchymal marker expression, respectively. In this study, we confirmed that the cAMP analogues, 8-CPT-cAMP or N6-Ph-cAMP, inhibited the TGF-β1-driven overexpression of the mesenchymal markers ZEB-1, Slug, Fibronectin, and α-SMA. Furthermore, we showed that A1, A2A, P2Y1, P2Y11, and P2X7 purine receptor agonists modulated the TGF-β1-induced EMT through the involvement of PKA and/or MAPK/ERK signaling. The stimulation of A2A receptor reduced the overexpression of the EMT-related markers, mainly through the cAMP-dependent PKA pathway, as confirmed by cell pre-treatment with Myr-PKI. Both A1 and P2Y1 receptor stimulation exacerbated the TGF-β1-driven effects, which were reduced by cell pre-treatment with the MAPK inhibitor PD98059, according to the increased ERK1/2 phosphorylation upon receptor activation. The effects induced by P2Y11 receptor activation were oppositely modulated by PKA or MAPK inhibition, in line with the dual nature of the Gs- and Gq-coupled receptor. Differently, P2X7 receptor induced, per se, similar and not additive effects compared to TGF-β1, after prolonged cell exposure to BzATP. These results suggest a putative role of purine receptors as target for anti-fibrotic agents.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO201910256436673ZK.pdf 3520KB PDF download
  文献评价指标  
  下载次数:13次 浏览次数:3次